Blog
Creasallis Blog provides updates on company news and insights into website optimization solutions from Cambridge Science Park.

Creasallis is an antibody solutions company whose patented CreaTap modification can be incorporated into existing antibodies for cancer drug developers.
creasallis.comCrawled Nov 3, 2026
Creasallis Blog provides updates on company news and insights into website optimization solutions from Cambridge Science Park.
Creasallis won the CambridgeLive Business Award for startup business of the year in 2023.
Cambridge-based startup Creasallis has been named as the Cambridgeshire Startup of the year at the East of England finals of the StartUp Awards 2023 on the 29th of June.
Creasallis won 50 EVOLVE Pipettes and accessories through a startup competition with Integra Biosciences.
Creasallis describes its biotech team, specializing in antibody therapeutics and innovative biotechnology solutions.
antibody engineering tumour penetration oncology antibody therapeutics
Company with a creative approach to science, improving existing antibodies with simple plug-and-play engineering - tumour antibody penetration technology.
Creasallis outlines its data collection practices, user privacy rights, and use of cookies and tracking technologies in its Privacy Policy.
Creasallis founder Zahra Jawad develops antibody engineering to target solid tumors. She secured early funding from US investors despite an initial rejection from Cambridge backers. The company focuses on re-engineering antibodies for improved tumor penetration and efficacy.
Creasallis, a biotechnology company specializing in antibody-based medicines, raises **$1.0 million** to advance its engineered therapeutic solutions. The funding supports its focus on structural and molecular biology to develop more effective treatments. The company’s expertise drives innovation in antibody-based drug development.
Creasallis develops next-generation antibody therapies targeting the tumor microenvironment. Monoclonal antibodies now dominate cancer treatments, offering precision over traditional chemotherapy. The company focuses on overcoming resistance mechanisms that limit current biologics’ efficacy.
Creasallis secures the **Startup Business of the Year 2023** at the CambridgeLive Business Awards, competing against two other Cambridgeshire businesses across all sectors. The company was recognized for its achievements at an event held at King’s College, Cambridge, featuring networking and entertainment.
The *Cambridge Independent* announces the recipients of its **Science and Technology Awards 2022**. The awards recognize individuals and organizations contributing to advancements in science and technology within the Cambridge region. Specific winners and their achievements are highlighted in the ceremony.